Urist Marshall Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
9
Insider Sells Sum
$5.87M

Insider Activity of Urist Marshall

According to the SEC Form 4 filings, Urist Marshall, being in a position of

  1. EVP, Research & Investments at Royalty Pharma plc,
    оver the last 12 months, has bought 0 shares, and sold 296968 shares for $12.54M,
    over all time since 2021-05-20, has bought 0 shares, and sold 436401 share for $18.42M.

Biography of Urist Marshall

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $12,543,13916100

Comparison of Insiders on Amount of Buys and Sells

2026-10-05SaleRoyalty Pharma plc
RPRX
EVP, Research & Investments
4,126
0.0009%
$57.10$235,595+9.69%
2026-09-28SaleRoyalty Pharma plc
RPRX
EVP, Research & Investments
4,126
0.0009%
$57.88$238,813+2.7%
2026-07-01SaleRoyalty Pharma plc
RPRX
EVP, Research & Investments
9,099
0.0021%
$55.88$508,454+5.33%
2026-06-24SaleRoyalty Pharma plc
RPRX
EVP, Research & Investments
9,098
0.0021%
$55.18$502,067+8.15%
2026-05-20SaleRoyalty Pharma plc
RPRX
EVP, Research & Investments
13,684
0.0032%
$52.75$721,838+10.12%
2026-05-14SaleRoyalty Pharma plc
RPRX
EVP, Research & Investments
13,684
0.0032%
$53.06$726,137+9.78%
2026-01-30SaleRoyalty Pharma plc
RPRX
EVP, Research & Investments
20,000
0.0045%
$41.09$821,810+33.89%
2026-01-23SaleRoyalty Pharma plc
RPRX
EVP, Research & Investments
20,000
0.0046%
$40.26$805,110+37.42%
2026-01-16SaleRoyalty Pharma plc
RPRX
EVP, Research & Investments
20,000
0.0046%
$39.52$790,346+40.04%
2026-01-09SaleRoyalty Pharma plc
RPRX
EVP, Research & Investments
20,000
0.0047%
$40.78$815,634+37.01%
2026-01-02SaleRoyalty Pharma plc
RPRX
EVP, Research & Investments
20,000
0.0046%
$38.48$769,650+41.29%
2025-12-26SaleRoyalty Pharma plc
RPRX
EVP, Research & Investments
20,000
0.0046%
$39.32$786,380+39.61%
2025-12-19SaleRoyalty Pharma plc
RPRX
EVP, Research & Investments
20,000
0.0046%
$38.38$767,582+41.19%
2025-12-16SaleRoyalty Pharma plc
RPRX
EVP, Research & Investments
20,000
0.0046%
$38.32$766,420+41.67%
2025-12-05SaleRoyalty Pharma plc
RPRX
EVP, Research & Investments
41,576
0.0094%
$39.15$1.63M+35.59%
2025-12-01SaleRoyalty Pharma plc
RPRX
EVP, Research & Investments
41,575
0.0096%
$39.92$1.66M+34.19%
2023-02-22SaleRoyalty Pharma plc
RPRX
EVP, Research & Investments
23,333
0.0073%
$37.30$870,239-18.6%
2022-07-25SaleRoyalty Pharma plc
RPRX
EVP, Research & Investments
19,734
0.0072%
$43.20$852,461-9.08%
2022-06-24SaleRoyalty Pharma plc
RPRX
EVP, Research & Investments
23,333
0.0085%
$43.19$1.01M-7.63%
2022-05-16SaleRoyalty Pharma plc
RPRX
EVP, Research & Investments
23,333
0.0078%
$39.85$929,836+1.22%
Total: 25
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.